Ischemia modified albumin: A potential marker for global metabolic risk in generalized anxiety disorder and panic disorder (eng)

INTRODUCTION[|]Ischemia modified albumin (IMA) is an altered type of albumin produced due to exposure to hypoxia, acidosis, inflammation, or oxidative stress. In this study, we aimed to evaluate the serum IMA levels in newly diagnosed and medication-naive generalized anxiety disorder (GAD) and panic...

Full description

Bibliographic Details
Main Authors: Esra Kabadayı Sahin, Gökçen Turan, Salim Neselioglu, Murat Ilhan Atagün
Format: Article
Language:English
Published: ANP Publishing 2021-05-01
Series:Klinik Psikiyatri Dergisi
Subjects:
Online Access:https://jag.journalagent.com/z4/download_fulltext.asp?pdir=kpd&un=KPD-49404
_version_ 1797909633070792704
author Esra Kabadayı Sahin
Gökçen Turan
Salim Neselioglu
Murat Ilhan Atagün
author_facet Esra Kabadayı Sahin
Gökçen Turan
Salim Neselioglu
Murat Ilhan Atagün
author_sort Esra Kabadayı Sahin
collection DOAJ
description INTRODUCTION[|]Ischemia modified albumin (IMA) is an altered type of albumin produced due to exposure to hypoxia, acidosis, inflammation, or oxidative stress. In this study, we aimed to evaluate the serum IMA levels in newly diagnosed and medication-naive generalized anxiety disorder (GAD) and panic disorder (PD) patients.[¤]METHODS[|]This cross-sectional study included medication-naive 23 GAD, 25 PD patients, and 28 healthy controls. The participants were evaluated with a sociodemographic form, the Beck Depression Inventory (BDI), and the Beck Anxiety Inventory (BAI). Venous blood samples were collected from all participants, and IMA levels and routine biochemical parameters were measured.[¤]RESULTS[|]There was no statistically significant difference between three groups in terms of age, gender, body mass index (BMI) and routine biochemical markers of the participants (p>0.05). The GAD and PD groups had significantly higher serum IMA levels than healthy controls (p<0.01), whereas there was no statistically significant difference in IMA levels between GAD and PD groups (p=0.994). Additionally, correlation analysis showed a positive correlation between IMA levels with BDI and BAI scores (r=0.449 and r=0.632, respectively, p<0.001).[¤]DISCUSSION AND CONCLUSION[|]Higher IMA levels in patients with GAD and PD may indicate metabolic stress on these patients. Anxiety disorders may tend to various biochemical disturbances, and IMA could be an important new marker that indicates global metabolic risk in such patients. This research is the first study that evaluates IMA levels in anxiety disorders.[¤]
first_indexed 2024-04-10T11:12:43Z
format Article
id doaj.art-9eedfb98305e4380a1ac43d92d86f725
institution Directory Open Access Journal
issn 1302-0099
language English
last_indexed 2024-04-10T11:12:43Z
publishDate 2021-05-01
publisher ANP Publishing
record_format Article
series Klinik Psikiyatri Dergisi
spelling doaj.art-9eedfb98305e4380a1ac43d92d86f7252023-02-15T16:19:02ZengANP PublishingKlinik Psikiyatri Dergisi1302-00992021-05-0124215315910.5505/kpd.2020.49404KPD-49404Ischemia modified albumin: A potential marker for global metabolic risk in generalized anxiety disorder and panic disorder (eng)Esra Kabadayı Sahin0Gökçen Turan1Salim Neselioglu2Murat Ilhan Atagün3Department of Psychiatry, Dr Abdurrahman Yurtaslan Ankara Oncology Research and Training Hospital, Ankara, TurkeyDepartment of Psychiatry, Ankara City Hospital, Ankara, TurkeyDepartment of Biochemistry, Ankara Yildirim Beyazit University Medical School, Ankara,Department of Psychiatry, Ankara Yildirim Beyazit University Medical School, AnkaraINTRODUCTION[|]Ischemia modified albumin (IMA) is an altered type of albumin produced due to exposure to hypoxia, acidosis, inflammation, or oxidative stress. In this study, we aimed to evaluate the serum IMA levels in newly diagnosed and medication-naive generalized anxiety disorder (GAD) and panic disorder (PD) patients.[¤]METHODS[|]This cross-sectional study included medication-naive 23 GAD, 25 PD patients, and 28 healthy controls. The participants were evaluated with a sociodemographic form, the Beck Depression Inventory (BDI), and the Beck Anxiety Inventory (BAI). Venous blood samples were collected from all participants, and IMA levels and routine biochemical parameters were measured.[¤]RESULTS[|]There was no statistically significant difference between three groups in terms of age, gender, body mass index (BMI) and routine biochemical markers of the participants (p>0.05). The GAD and PD groups had significantly higher serum IMA levels than healthy controls (p<0.01), whereas there was no statistically significant difference in IMA levels between GAD and PD groups (p=0.994). Additionally, correlation analysis showed a positive correlation between IMA levels with BDI and BAI scores (r=0.449 and r=0.632, respectively, p<0.001).[¤]DISCUSSION AND CONCLUSION[|]Higher IMA levels in patients with GAD and PD may indicate metabolic stress on these patients. Anxiety disorders may tend to various biochemical disturbances, and IMA could be an important new marker that indicates global metabolic risk in such patients. This research is the first study that evaluates IMA levels in anxiety disorders.[¤]https://jag.journalagent.com/z4/download_fulltext.asp?pdir=kpd&un=KPD-49404ischemia modified albumingeneralized anxiety disorderpanic disorder
spellingShingle Esra Kabadayı Sahin
Gökçen Turan
Salim Neselioglu
Murat Ilhan Atagün
Ischemia modified albumin: A potential marker for global metabolic risk in generalized anxiety disorder and panic disorder (eng)
Klinik Psikiyatri Dergisi
ischemia modified albumin
generalized anxiety disorder
panic disorder
title Ischemia modified albumin: A potential marker for global metabolic risk in generalized anxiety disorder and panic disorder (eng)
title_full Ischemia modified albumin: A potential marker for global metabolic risk in generalized anxiety disorder and panic disorder (eng)
title_fullStr Ischemia modified albumin: A potential marker for global metabolic risk in generalized anxiety disorder and panic disorder (eng)
title_full_unstemmed Ischemia modified albumin: A potential marker for global metabolic risk in generalized anxiety disorder and panic disorder (eng)
title_short Ischemia modified albumin: A potential marker for global metabolic risk in generalized anxiety disorder and panic disorder (eng)
title_sort ischemia modified albumin a potential marker for global metabolic risk in generalized anxiety disorder and panic disorder eng
topic ischemia modified albumin
generalized anxiety disorder
panic disorder
url https://jag.journalagent.com/z4/download_fulltext.asp?pdir=kpd&un=KPD-49404
work_keys_str_mv AT esrakabadayısahin ischemiamodifiedalbuminapotentialmarkerforglobalmetabolicriskingeneralizedanxietydisorderandpanicdisordereng
AT gokcenturan ischemiamodifiedalbuminapotentialmarkerforglobalmetabolicriskingeneralizedanxietydisorderandpanicdisordereng
AT salimneselioglu ischemiamodifiedalbuminapotentialmarkerforglobalmetabolicriskingeneralizedanxietydisorderandpanicdisordereng
AT muratilhanatagun ischemiamodifiedalbuminapotentialmarkerforglobalmetabolicriskingeneralizedanxietydisorderandpanicdisordereng